Related Experiment Video
Updated: Aug 10, 2026

Protocols for Vaginal Inoculation and Sample Collection in the Experimental Mouse Model of Candida vaginitis
Published on: December 8, 2011
Systemic candidiasis in mice treated with prednisolone and amphotericin B. 2. Ultrastructure and evidence for fungal
Abstract:
The principal ultrastructural changes in cells of Candida albicans treated with amphotericin B (AmB), either in vitro or in vivo, and in the presence or absence of prednisolone included plasmolysis, vacuolation and destruction of organelles. Lamination of the cell wall, although discernible after 4 h antibiotic treatment in vitro, was conspicuous in vivo, especially in prednisolone-treated mice given AmB 72 h after inoculation and was seen in both phagocytosed cells and those free in inflammatory exudates. Somatic extracts from control cells and somatic extracts and leachates from AmB-treated cells showed the presence of low-grade toxic components when given i.p. to mice receiving antinomycin D(AMD) s.c. Culture filtrates were negative. Eighteen hour cultures were more toxic than those grown for 3 days and no toxicity was shown for cultures after 8 or 14 days. The behaviour of toxic materials during electrophoresis in polyacrylamide gels suggested that they were proteins of relatively high molecular weight.
Insights
Amphotericin B (AmB) causes ultrastructural damage to Candida albicans cells, including cell wall changes and organelle destruction. Toxic protein components were detected in AmB-treated fungal extracts, impacting mice treated with Actinomycin D.
Area of Science:
- Mycology
- Cell Biology
- Pharmacology
Background:
- Candida albicans is a common fungal pathogen.
- Amphotericin B (AmB) is a key antifungal agent.
- Prednisolone can modulate host response to infection.
Purpose of the Study:
- To investigate the ultrastructural effects of Amphotericin B on Candida albicans cells.
- To assess the toxicity of Amphotericin B-treated Candida albicans extracts.
- To determine the influence of prednisolone on these effects.
Main Methods:
- Transmission electron microscopy to observe cellular ultrastructure.
- In vitro and in vivo treatment of Candida albicans with Amphotericin B.
- Administration of fungal extracts and leachates to mice, with or without Actinomycin D.
- Polyacrylamide gel electrophoresis to analyze toxic components.
Main Results:
- Amphotericin B induced plasmolysis, vacuolation, and organelle destruction in Candida albicans.
- Cell wall lamination was prominent in vivo, particularly with prednisolone co-treatment.
- Somatic extracts and leachates from treated cells exhibited low-grade toxicity in mice.
- Toxic components were identified as high molecular weight proteins.
Conclusions:
- Amphotericin B causes significant cellular damage to Candida albicans.
- Prednisolone may enhance the in vivo effects of Amphotericin B on fungal cell walls.
- Fungal extracts from Amphotericin B treatment contain toxic, proteinaceous components.
Related Concept Videos
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Candidiasis
Antifungal Agents

